New Zealand markets closed

G1 Therapeutics, Inc. (GTHX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.6100-0.0300 (-0.65%)
At close: 04:00PM EDT
4.6900 +0.08 (+1.74%)
Pre-market: 07:13AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 196.87M
Enterprise value 95.98M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.10
Price/book (mrq)1.97
Enterprise value/revenue 3.97
Enterprise value/EBITDA -0.59

Trading information

Stock price history

Beta (5Y monthly) 1.92
52-week change 3-78.52%
S&P500 52-week change 3-3.35%
52-week high 324.1200
52-week low 34.3150
50-day moving average 37.2760
200-day moving average 311.2703

Share statistics

Avg vol (3-month) 3822.05k
Avg vol (10-day) 31.13M
Shares outstanding 542.71M
Implied shares outstanding 6N/A
Float 835.9M
% held by insiders 19.03%
% held by institutions 172.36%
Shares short (28 Apr 2022) 46.56M
Short ratio (28 Apr 2022) 410.44
Short % of float (28 Apr 2022) 417.26%
Short % of shares outstanding (28 Apr 2022) 415.35%
Shares short (prior month 30 Mar 2022) 46.33M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-452.59%

Management effectiveness

Return on assets (ttm)-36.90%
Return on equity (ttm)-92.46%

Income statement

Revenue (ttm)31.48M
Revenue per share (ttm)0.75
Quarterly revenue growth (yoy)-65.00%
Gross profit (ttm)29.46M
EBITDA -141.99M
Net income avi to common (ttm)-148.35M
Diluted EPS (ttm)-3.5370
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)221.19M
Total cash per share (mrq)5.18
Total debt (mrq)83.06M
Total debt/equity (mrq)57.86
Current ratio (mrq)8.82
Book value per share (mrq)3.37

Cash flow statement

Operating cash flow (ttm)-132.11M
Levered free cash flow (ttm)-78.29M